Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 10—October 2012

West Nile Virus Meningoencephalitis Imported into Germany

Jörg Schultze-Amberger1, Petra Emmerich1, Stephan Günther, and Jonas Schmidt-ChanasitComments to Author 
Author affiliations: Klinikum Ernst von Bergmann, Potsdam, Germany (J. Schultze-Amberger); and Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (P. Emmerich, S. Günther, J. Schmidt-Chanasit)

Main Article


Results of indirect immunofluorescence assays performed on serum and CSF samples from patient with suspected WNV infection, Germany, 2011*

Virus used as antigen Ig class Antibody titer in serum
Antibody titer in CSF
Day 4 Day 6 Day 11 Day 26 Day 4 Day 6
WNV IgG 320 1,280 5,120 10,240 20 40
WNV IgM 160 160 1,280 1,280 10 20
SLEV IgG 80 80 1,280 2,560 <10 <10
SLEV IgM 20 20 40 <20 <10 <10
JEV IgG ND <20 ND 1,280 ND <10
JEV IgM ND <20 ND <20 ND <10
DENV IgG ND 80 ND 640 ND <10
DENV IgM ND 20 ND <20 ND <10
YFV IgG ND <20 ND ND ND <10
YFV IgM ND. <20 ND ND ND <10
TBEV IgG ND <20 ND ND ND <10
TBEV IgM ND <20 ND ND ND <10

*CSF, cerebrospinal fluid; WNV, West Nile virus; SLEV, St. Louis encephalitis virus; JEV, Japanese encephalitis virus; ; ND, not done; DENV, dengue virus; YFV, yellow fever virus; TBEV, tick-borne encephalitis virus. Titers <20 for serum and <10 for CSF are considered negative.

Main Article

1These authors contributed equally to this article.

Page created: September 19, 2012
Page updated: September 19, 2012
Page reviewed: September 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.